Podcasts about Fellow

From August 9, 2024: On today's episode, Lawfare's Fellow in Technology Policy and Law Eugenia Lostri speaks with Senior Privacy Engineer at Netflix and former Army Reserve intelligence officer, Lukas Bundonis. They talked about the relationship between law enforcement and tech companies, what that relationship looks like in the U.S. and other countries, and the different ways in which that communication can be politicized.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

From November 29, 2023: Unless you've been living under a rock, you've probably heard a great deal over the last year about generative AI and how it's going to reshape various aspects of our society. That includes elections. With one year until the 2024 U.S. presidential election, we thought it would be a good time to step back and take a look at how generative AI might and might not make a difference when it comes to the political landscape. Luckily, Matt Perault and Scott Babwah Brennen of the UNC Center on Technology Policy have a new report out on just that subject, examining generative AI and political ads.On this episode of Arbiters of Truth, our series on the information ecosystem, Lawfare Senior Editor Quinta Jurecic and Lawfare's Fellow in Technology Policy and Law Eugenia Lostri sat down with Matt and Scott to talk through the potential risks and benefits of generative AI when it comes to political advertising. Which concerns are overstated, and which are worth closer attention as we move toward 2024? How should policymakers respond to new uses of this technology in the context of elections?To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

Editorial Fellow Dr David Oxman joins Ethics Talk to discuss the November 2025 issue of the Journal: "Electronic Health Record Evolution."  Recorded August 12, 2025. 

In hour 3, Mark is joined by Tanner Nau, a Fellow at The Free Press. He discusses his latest story which is headlined, "The College Kids Who Can't Do Basic Math." Mark is then joined by Eureka Fire Chief Greg Brown who discusses the upcoming Mark Reardon Show live broadcast at Helen Fitzgerald's which will help promote Guns 'N Hoses. He's later joined by Ryan Graceface, the Head of Indie Record Label Graveface Records. He discusses the record label celebrating their 25 year anniversary. They wrap up the show with the Audio Cut of the Day.

In hour 1 of The Mark Reardon Show, Mark is joined by the Reardon Roundtable which is made up of Jane Dueker, Jeff Smith and Gregg Keller. They discuss and debate the winners and losers of the government shutdown, Democrats once again trying to connect Trump with the Epstein files and more. In hour 2, Sue hosts, "Sue's News" where she discusses the latest trending entertainment news, this day in history, the random fact of the day and much more. Mark is then joined by Paul Hall with Common Guy Film Reviews. He discusses upcoming releasing movies and shows to watch. He's later joined by KSDK Sports Director Frank Cusumano who discusses Mizzou football and basketball and other local sports. In hour 3, Mark is joined by Tanner Nau, a Fellow at The Free Press. He discusses his latest story which is headlined, "The College Kids Who Can't Do Basic Math." Mark is then joined by Eureka Fire Chief Greg Brown who discusses the upcoming Mark Reardon Show live broadcast at Helen Fitzgerald's which will help promote Guns 'N Hoses. He's later joined by Ryan Graceface, the Head of Indie Record Label Graveface Records. He discusses the record label celebrating their 25 year anniversary. They wrap up the show with the Audio Cut of the Day.

John Murray, Ali Bruce-Ball & Conor McNamara talk football, travel & language after Cristiano Ronaldo sees red as Republic of Ireland beat Portugal, and England beat Serbia. What about the ‘mind-altering' shoes some of the England players are wearing? There's a European theme to Clash of the Commentators. And suggestions always welcome for our Great Glossary of Football Commentary and unintended pub names from football commentary - WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk00:40 Conor fresh from Ireland-Portugal 04:40 Takeaways from England-Serbia 06:05 Mind-altering shoes & commentary attire 16:05 5 Live commentaries this weekend 18:00 John prepares for trip to Albania 24:55 Unintended (and intended) pub names 33:15 Clash of the Commentators 41:45 Great Glossary of Football Commentary 52:55 Magazine memories5 Live / BBC Sounds Premier League commentaries: Fri 1945 Slovakia v Northern Ireland on Sports Extra, Sat 1330 Man City v Man Utd in WSL on Sports Extra, Sat 1700 Liechtenstein v Wales on Sports Extra, Sat 1945 Greece v Scotland on 5 Live, Sun 1200 Liverpool v Chelsea in WSL on Sports Extra, Sun 1200 Brighton v Leicester in WSL on Sports Extra 2, Sun 1430 Tottenham v Arsenal in WSL on 5 Live, Sun 1700 Albania v England on 5 Live, Mon 1945 Northern Ireland v Luxembourg on Sports Extra, Tue 1945 Scotland v Denmark on 5 Live, Tue 1945 Wales v North Macedonia on Sports Extra, Wed 2000 Arsenal v Real Madrid in UWCL on 5 Live, Thu 2000 Chelsea v Barcelona in UWCL on 5 Live.Glossary so far (in alphabetical order):DIVISION ONE Bosman, Cruyff Turn, Dead-ball specialist, Fox in the box, Giving the goalkeeper the eyes, Head tennis, Hibs it, In a good moment, Leading the line The Maradona, Olimpico, Onion bag, Panenka, Rabona, Scorpion kick, Spursy, Tiki-taka, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep.DIVISION TWO Ball stays hit, Business end, Came down with snow on it, Cauldron atmosphere Coat is on a shoogly peg, Come back to haunt them, Easy tap-in, Daisycutter, First cab off the rank, Has that in his locker, High wide and not very handsome, Howler, One for the cameras, One for the purists, Played us off the park, Purple patch, Put their laces through it, Rolls Royce, Root and branch review, Row Z, Seats on the plane, Show across the bows, Stramash, Taking one for the team, That's great… (football), Thunderous strike.UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Bread and butter, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Cultured/Educated left foot, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Nutmeg, Opposite number, Park the bus, PK for penalty-kick, Postage stamp, Put it in the mixer, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Roy of the Rovers stuff, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, We've got a cup tie on our hands, Winger in their pocket, Wrap foot around it, Your De Bruynes, your Gundogans etc.

Today I am deeply honored to spend time with poet, activist, and scholar Jamaica Osorio. Shortly after October 7, 2023, she began to write a series of astonishing poems about the war in Gaza and the genocide. Osorio graces us with readings of some of those poems, and engages in a rich, complex, and deeply moving discussion of what went into their composition. Throughout, we talk about the power of poetry to suspend time and allow us the space to contemplate the impossible.  We talk about the nature of not knowing, of the inexpressible, and the ways certain poems can give us the strength, energy, and commitment to persist in working for the liberation of all peoples, even when dwelling in grief.Dr. Jamaica Heolimeleikalani Osorio is a Kanaka Maoli wahine artist / activist / scholar / storyteller born and raised in Pālolo Valley to parents Jonathan and Mary Osorio. Jamaica earned her PhD in English (Hawaiian literature) in 2018 from the University of Hawaiʻi at Mānoa. Currently, Jamaica is an Associate Professor of Indigenous and Native Hawaiian Politics at the University of Hawaiʻi at Mānoa. In 2020 her poetry and activism were the subject of an award-winning film, This is the Way we Rise which premiered at Sundance Film Festival in 2021.  In 2022 she was a lead artist and Co-writer of the revolutionary VR Documentary, On the Morning You Wake (To the end of the world),  that premiered at Sundance Film Festival 2022 and won the XR experience Jury award at SXSW 2022. She is a proud past Kaiāpuni student, Ford Dissertation (2017) and Post Doctoral (2022) Fellow, and a graduate of Kamehameha, Stanford University (BA) and New York University (MA). She is the author of the award winning book Remembering our Intimacies: Moʻolelo, Aloha ʻĀina, and Ea which was published in 2021 by The University of Minnesota Press. She believes in the power of aloha ʻāina and collective action to pursue liberatory, decolonial, and abolitionist futures of abundance.

Thanksgiving hasn't even reared it's ugly turkey face & already the boys are deep into the official release of the 32 Christmas flicks that make up this years Holiday Cheermeister Award Championship Hall of Fame. Fellow attorney Hollie Lindsey graces them with her presents to talk all about her life, her love for Saint Nick, followed by her immense disdain for Will Ferrel and Elf. It's a charcuterie board of festive mayhem. Great Law. Less Legal. Law Done Lite!

RNZ reporter Kate Green has recently returned from parts of Southeast Asia as part of a Jefferson Fellowship exploring food security issues across the region. You can find photos and read more about the stories in this episode on our webpage, here.With thanks to:Kate GreenGo to this episode on rnz.co.nz for more details

Follow Everyday Encounters with the Lord on Facebook.

In this segment, Mark is joined by Tanner Nau, a Fellow at The Free Press. He discusses his latest story which is headlined, "The College Kids Who Can't Do Basic Math."

The United Kingdom has set an ambitious target to achieve a decarbonised power system by 2030 as part of its broader Net Zero commitment. Delivering on this goal is central to strengthening energy security, enhancing resilience, and ensuring affordable, clean power for households and industry. In his address to the IIEA, Chris Stark, Head of the UK Government's Mission for Clean Power, outlines the UK's pathway to Net Zero and discuss the role of interconnectors, infrastructure, and investment in delivering a secure and sustainable energy system. Drawing on his leadership of the UK government's “Mission Control” for clean power, Mr Stark also reflects on the challenges and opportunities of transforming the UK's energy landscape amid an increasingly complex global environment. This event is part of the IIEA's REthink Energy series, organised in partnership with ESB. Speaker bio: Chris Stark was appointed head of the UK's Mission for Clean Power in the UK's Department for Energy Security and Net Zero in July 2024. Previous to this, he was Chief Executive of the Climate Change Committee from April 2018 for six years. Under his leadership, the committee recommended a UK net zero target for greenhouse gas emissions by 2050 – a target that is now in law. He was Director of Energy and Climate Change in the Scottish Government from May 2016 to April 2018. He has also served as Chief Executive of the Carbon Trust and is currently Honorary Professor at the University of Glasgow's Centre for Public Policy, a Fellow of the Royal Society of Edinburgh, and is on the board of climate charity Murmer.

On November 12, our church family gathered to hear from Christopher Watkin, author of Biblical Critical Theory. Over the course of the evening, Dr. Watkin helped us rethink one of culture's most persistent questions: Who am I? Drawing on everything from Star Wars to Viktor Frankl to the biblical narrative itself, he showed us why the stories we live in shape us far more than we realize, and why the gospel offers a truer, richer, and more hope-filled story than any we could possibly write for ourselves.ABOUT CHRISTOPHER WATKINChristopher joined us from Melbourne, Australia, where he is a Senior Lecturer in French Studies at Monash University. He is a Fellow of The Keller Center for Cultural Apologetics, a leading voice at the intersection of philosophy, theology, and cultural critique, and recently authored Biblical Critical Theory. His writing traces how individuals and societies make sense of the world—especially when confronted with contrasting beliefs and ideas. As a Christian thinker and teacher, Dr. Watkin brings deep intellectual rigor to bear on questions of meaning, culture, and faith in contemporary life.

Dr. Muhamad Aly Rifai is a highly respected internist and psychiatrist serving the Greater Lehigh Valley, Pennsylvania. As the CEO and Chief Psychiatrist and Internist of Blue Mountain Psychiatry, he leads with expertise and dedication to mental health and internal medicine. He also holds the distinguished title of Lehigh Valley Endowed Chair of Addiction Medicine, further solidifying his authority in the field.Dr. Rifai is Board Certified in multiple specialties, including Internal Medicine, Psychiatry, Addiction Medicine, and Psychosomatic Medicine, demonstrating his extensive knowledge and commitment to comprehensive patient care. His professional achievements have earned him recognition as a Fellow of the American College of Physicians, the Academy of Psychosomatic Medicine, and the American Psychiatric Association. Additionally, he has served as the President of the Lehigh Valley Psychiatric Society, contributing significantly to the advancement of psychiatric practice in the region.Learn more: http://www.alyrifai.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-dr-muhamad-aly-rifai-ceo-chief-psychiatrist-and-internist-of-blue-mountain-psychiatry

A Vet-Turned-Postal Worker is found crushed to death inside a giant mail sorting machine just days after his proposal. Fellow employees didn't find him until 8 hours later. A new lawsuit exposes an Army OBGYN's sick secret; it also states the military knew he was a "pervert in a uniform" and still allowed him to continue his alleged 'care.' Plus, a rollercoaster rider is KO'ed by a feathered foe...now, she's filed. Jennifer Gould reports. See omnystudio.com/listener for privacy information.

Get 90 Days of Fellow's AI Meeting Assistant FREE at fellow.ai/coo This week on Between Two COOs, Michael sits down with Harris Clarke, COO at GuideCX, to talk about what steady leadership actually looks like inside fast-changing companies.Harris started his career in protocol and operations for the U.S. Department of State, where “process” wasn't just a buzzword — it was survival. He shares how those lessons translate to running a modern SaaS organization and why purpose, process, and payoff are the anchors of any good meeting.They dig into:How government discipline shaped Harris's operating styleThe “three P's” framework for productive meetingsWhy decision speed is overrated — and what Harris means by “Did anyone die or go to jail?”What he learned from executive coaching and board feedbackHow GuideCX built a new product category around customer onboardingHow AI is quietly reshaping how he manages teams and prepares communicationsWhy calm is a competitive advantage during crisis moments like SVBMichael also gives context at the top: this episode was recorded across two sessions, after a recording issue mid-interview (and yes, he's now officially a Riverside convert).It's a conversation about building trust, running tight systems, and keeping your head when everything around you is changing.Harris Clarke on LinkedInGuideCXMichael Koenig on LinkedInBetween Two COO's WebsiteEpisode Website 

Dr. Muhamad Aly Rifai is a highly respected internist and psychiatrist serving the Greater Lehigh Valley, Pennsylvania. As the CEO and Chief Psychiatrist and Internist of Blue Mountain Psychiatry, he leads with expertise and dedication to mental health and internal medicine. He also holds the distinguished title of Lehigh Valley Endowed Chair of Addiction Medicine, further solidifying his authority in the field.Dr. Rifai is Board Certified in multiple specialties, including Internal Medicine, Psychiatry, Addiction Medicine, and Psychosomatic Medicine, demonstrating his extensive knowledge and commitment to comprehensive patient care. His professional achievements have earned him recognition as a Fellow of the American College of Physicians, the Academy of Psychosomatic Medicine, and the American Psychiatric Association. Additionally, he has served as the President of the Lehigh Valley Psychiatric Society, contributing significantly to the advancement of psychiatric practice in the region.Learn more: http://www.alyrifai.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-dr-muhamad-aly-rifai-ceo-chief-psychiatrist-and-internist-of-blue-mountain-psychiatry

Have a comment? I'd love to hear from you! S.4 Ep.11 - ALCOHOL: The Demon Drink? With Profs. Greg Whyte & Andy LaneHad a great chat with the Professors today, we spoke about both the physiological and psychological effects of alcohol. Phil shared a tragic personal story. For further reading on the issues we discussed, please use the link below:https://www.ias.org.uk/wp-content/uploads/2020/12/The-physical-and-mental-health-effects-of-alcohol.pdfDrinkline is the national alcohol helpline. If you're worried about your own or someone else's drinking, you can call this free helpline in complete confidence. Call 0300 123 1110 (weekdays 9am to 8pm, weekends 11am to 4pm).Get support here:https://www.drinkaware.co.uk/advice-and-support/alcohol-support-servicesFind out more about Professors Greg Whyte & Andy LaneInstagram @profgregwThe Whyte Answerhttp://www.thewhyteanswer.comBean Lite - The new Bespoke Exercise &  nutrition App https://itunes.apple.com/gb/app/bean-lite/id1299547415?mt=8Bump it Uphttps://www.amazon.co.uk/Bump-Up-flexible-exercise-pregnancy/dp/0593077482Achieve the Impossiblehttp://www.achievetheimpossible.co.ukFor more info on Prof Andy Lane:BPS Chartered Psychologist, HCPC Registered Psychologist, Fellow of BASESDirector of Research ExcellenceAssociate Dean, Faculty of Education, Health and Well-Being, University of Wolverhampton, UK, Walsall Campus, WS13BD, UKTwitter @Andylane27http://www.researchgate.net/profile/Andrew_Lanehttps://www.youtube.com/c/andylane27I hope you find this useful and enjoyed the podcast. Watch for the next episode soon, please subscribe when you can and please leave us a rating or review. It would really help if you shared this or any of these podcasts, with anyone who might find it useful. Click the link highlighted to find out more about Lee here.Please also join the Mature Muscle Podcast Facebook Group for the latest info.

This special mini-series, The People Behind the Progress, celebrates the finalists for the UK Space and Satellite Personality of the Year Award – A distinction that honors people whose ideas, integrity, and influence have advanced the UK's role on the global stage.  In the first episode of this mini-series, we hear from Dr. Alice Bunn, President of UKspace. Dr Alice Bunn is a globally recognised leader in science and engineering, with a distinguished career spanning strategic leadership, international diplomacy, and public engagement. Awarded an OBE in the Queen's Honours List in 2022 for her services to the UK space sector, Alice is President of the UKspace Trade Association and has a 25-year career in the space sector where she has held leadership positions in national, European and global contexts. Alice sits on the Advisory Board of Strategy International and acts as strategic advisor to a number of companies spanning the UK and international space sectors. As former Chief Executive of the Institution of Mechanical Engineers, she led a global organisation of over 115,000 members, where she successfully reversed a 15-year financial decline and implemented a transformative strategy focused on societal impact. Previously, Alice served as International Director at the UK Space Agency, where she secured record investments in the European Space Agency and pioneered new approaches to civil space security and infrastructure. Alice is a passionate advocate for science communication and is a chartered engineer. Alice is regularly called upon as a media expert contributor to all things space and engineering, appearing on BBC, Radio 4, ITN, Sky News and in demand as a speaker at international summits and conferences such as Davos, UN Summits, TEDx and more. Alice has a PhD in Metallurgy from Darwin College, University of Cambridge, and is also a Fellow of the Institution of Mechanical Engineers and the Royal Aeronautical Society. As an avid wild swimmer, she proudly sits as the Chair of the Board at SwimTayka, a drowning prevention charity that teaches kids in developing countries to swim.

Love Your Fellow As Yourself- Helping Someone Carry Their Load

Este es el episodio #134 de "Tradiciones Sabias", el podcast en español de la Fundación Weston A. Price. Algunos de los temas de este episodio - -Cómo recuperar y mantener un peso saludable -La importancia de una buena masa muscular -Cómo influyen la salud mental y el estrés en nuestro esfuerzo de mantener buena salud -El rol de la actividad física y el movimiento corporal -Qué es y cuán importante es la higiene del sueño Datos del invitado -  Diego es natural de México y se formó como Médico Cirujano por la Universidad Anáhuac. Posteriormente realizó la Especialidad en Obesidad y Comorbilidades, así como la Maestría en Nutriología Aplicada por la Universidad IberoAmericana.  Es creador de WODBOX®️, la cadena de gimnasios funcionales y 1er licencia de CrossFit en el país. Cuenta con múltiples certificaciones como Levantamiento Olímpico de Pesas, Kettlebells y Deportes de Resistencia.  Creció en su Práctica Privada desde el 2014 entremezclando la Medicina Regenerativa, Funcional y del Estilo de Vida, con enfoque primariamente preventivo. Realizó el Fellow en Medicina Funcional en el Institute for Functional Medicine. Es Miembro Fundador de la Asociación Mexicana de Medicina del Estilo de Vida. Fue Director Médico de Biocenter, Centro Pionero de Medicina Regenerativa en México. Se desempeñó como responsable del Departamento de Medicina Regenerativa y Well Aging en SHA Wellness, en Cancún Quintana Roo. Hoy tiene su práctica privada en  Ker Clinic (clínica especializada en Trastornos del Espectro Autista) y es co-creador del área de Medicina Regenerativa y Funcional con tratamientos de última generación para la atención profiláctica y terapéutica en esta clínica. Es Promotor acérrimo de Agricultura y Ganadería Regenerativa como fuente de Alimentación Ancestral en la actualidad. Disfruta de leer,  de ir al cine y al teatro, hacer ejercicio con Kettlebells y caminar, y si es al aire libre en alguna montaña o algún lugar de playa, mejor. Contacto - Instagram: drdiegomc Recursos en español de la Fundación Weston A. Price -   Página web WAPF en Español: https://www.westonaprice.org/espanol/ Cuenta de Instagram: westonaprice_espanol Guía alimentación altamente nutritiva, saludable y placentera: 11 principios dietéticos Paquete de Materiales GRATIS: https://secure.westonaprice.org/CVWEBTEST_WESTON/cgi-bin/memberdll.dll/openpage?wrp=customer_new_infopak_es.htm  Folleto "La Leche Real", de Sally Fallon:  https://www.westonaprice.org/wp-content/uploads/La-leche-real.pdf  Música de Pixabay - Sound Gallery y SOFRA  

Send us a textMark Loughney's art has been exhibited at the Museum of Modern Art (“MoMa PS-1”), and published in The New Yorker and The Atlantic.  His black-and-white ink drawings evoke a mix of M.C. Escher and Salvadore Dali, with surreal landscapes and bizarre figures.  But Loughney is also well known for his series of prison portraits.  They're prison portraits, not only because they depict prisoners, but also because they were drawn when Loughney himself was serving a 10-year sentence as an inmate at Pennsylvania State Correctional Institution – Dallas.  That is where Loughney's portraiture blossomed, and his exhibitions began.  

We have officially reached the halfway mark in the Champions League's League Phase, which featured some surprising results across Europe. Nick and Taylor analyze all 18 matches, which featured a sensational match in Paris between PSG and Bayern, a thrilling contest in Belgium between Club Brugge and Barcelona, and some huge wins for struggling clubs aspiring to reach the safe zone of the top-24. The European football experts also take the time to berate Atalanta for their managerial mishaps. Timestamps: 0:00-1:38 Intro 1:39-17:41 PSG vs Bayern 17:42-25:31 Liverpool vs Real Madrid 25:32-29:26 Napoli vs Eintracht Frankfurt 29:27-37:12 Juventus vs Sporting 37:13-41:13 Slavia Praha vs Arsenal 41:14-45:18 Tottenham vs Copenhagen 45:19-51:45 Atletico Madrid vs USG 51:46-54:52 Olympiacos vs PSV 54:53-58:02 Bodo/Glimt vs Monaco 58:03-01:04:52 Club Brugge vs Barcelona 01:04:53-01:10:29 Man City vs Dortmund 01:10:30-01:16:52 Newcastle vs Athletic Club 01:16:53-01:28:01 Marseille vs Atalanta 01:28:02-01:32:14 Benfica vs Leverkusen 01:32:15-01:37:15 Ajax vs Galatasaray 01:37:16-01:41:58 Qarabag vs Chelsea 01:41:59-01:45:23 Pafos vs Villarreal 01:45:24-01:51:25 Inter vs Kairat Almaty 01:51:26-01:56:10 Matchday 5 Preview

The sermon centers on the profound unity of Jews and Gentiles in the Church, made possible not by human effort or merger, but by the miraculous work of Christ on the cross. Drawing from Ephesians 2:11–22, it emphasizes that both groups were once separated by law, culture, and identity—Gentiles as outsiders, Jews as privileged under the Mosaic covenant—but Christ has abolished the dividing wall by fulfilling the law and creating one new humanity in Himself. This unity is not based on external markers like circumcision, tradition, or denominational affiliation, but on the shared reality of being reconciled to God through faith in Christ, who is our peace and the cornerstone of the spiritual temple. The passage calls believers to remember their former state—estranged from God and each other—so they may fully embrace their present identity as fellow citizens of God's household and members of a living, growing body built by the Holy Spirit. The sermon challenges modern individualism and cultural trends that prioritize personal preference over communal faith, urging the church to take seriously its role as a unified, holy dwelling place of God, where every believer, regardless of background, belongs and contributes to the collective spiritual edifice.

On this episode of the Energy Security Cubed Podcast, we feature the audio from two segments from the CGAI Energy Security Forum Conference, "Canada's Next Chapter in the Indo-Pacific", featuring MP Ellis Ross and the Institute of Energy Economics, Japan's Jun Nishizawa. // For the podcast's intro section, Joe and Kelly discuss some of the key line items in the Budget with implications for Canadian energy infrastructure and the Major Projects Office. // Guest Bio: - Ellis Ross is MP for Skeena—Bulkley Valley and former Elected Chief Councilor of Haisla Nation - Jun Nishizawa is Visiting Fellow, Institute of Energy Economics, Japan // Host Bio: - Kelly Ogle is Managing Director of the Canadian Global Affairs Institute - Joe Calnan is a Fellow and Energy Security Forum Manager at the Canadian Global Affairs Institute // Interview recording Date: October 28, 2025 // Energy Security Cubed is part of the CGAI Podcast Network. Follow the Canadian Global Affairs Institute on Facebook, Twitter (@CAGlobalAffairs), or on LinkedIn. Head over to our website at www.cgai.ca for more commentary. // Produced by Joe Calnan. Music credits to Drew Phillips.

Remember being a teen and coming up with “cool” ways of spelling common words? Well, just like the teenager it was, the United States in the 18th century was annoying their mom, England, with the hip words that were being edited and added to their lexicon. The antagonistic pair of nations on the brink of the Revolutionary War were always competing to prove their superiority and independence in small cultural battles, and words themselves were no different. Fellow word-nerd Gabe Henry, author of Enough Is Enuf: Our Failed Attempts to Make English Easier to Spell, joins Sarah as they chummily pun their way through the story of the 18th century Dictionary Wars, the story of the publishing battles fought between a handful of eccentric word-lovers in The US and England, all vying for the future supremacy of their own spellings. Digressions include crop circles from Unsolved Mysteries, dishonest detergent marketing, and old fashioned sock puppet accounts.More Gabe Henry:gabehenry.comEnough Is Enuf: Our Failed Attempts to Make English Easier to SpellProduced + edited by Miranda ZicklerMore You're Wrong About:linktr.ee/ywapodBonus Episodes on PatreonBuy cute merchYWA on InstagramSupport the show

The U.S. has carried out multiple strikes on boats in the Caribbean off of Venezuela, killing dozens of people. And yet there's very little legal rationale for the military action we've seen. Benjamin Gedan is a senior fellow and director of the Latin America Program at the Stimson Center and Adjunct Lecturer and Fellow at Johns Hopkins School of Advanced International Studies. He also served as the South America director on the National Security Council staff in the Obama administration. Gedan joins WITHpod to discuss the U.S.' relationship with Venezuela, thoughts on regime changes, military pressure ratcheting up and more.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Filmmaker and U.S. Air Force veteran Ryan Begay (Diné) set out to bring some of the stories of others Native American veterans to a broader audience. In the process, he brings those stories, especially those of Native women who serve in the military to life, in the documentary, "Honor Song". We'll hear about the film and from some of those featured in it. Another Air Force veteran, Steven Sibley (Cherokee), also saw a need to connect with fellow military veterans and to provide a better source of information about the resources and benefits available to veterans and their family members. He now is co-publisher of the free Oklahoma Veterans News Magazine. We'll talk with him about his service in the military and ways veterans can connect with the benefits available to them. GUESTS Ryan Begay (Diné), producer, director, actor, and Air Force veteran Cassie Velarde Neher (Jicarilla Apache), Navy veteran and doctoral student at the University of New Mexico Darrell Charlee (Diné), Air Force Master Sgt. Steven Sibley (Delaware by blood and Cherokee by the Dawes Roll), retired, disabled veteran living in Oklahoma, and a co-publisher of Oklahoma Veterans New Magazine

The UK's medicines watchdog has said criminal gangs in the UK have started making their own weight-loss drugs, with packaging and branding designed to look like legitimate products. The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that the new trend poses a significant threat. Presenter Clare McDonnell is joined by Sukhi Basra, vice chair of the National Pharmacy Association who also runs a weight loss practice, to dicuss the risks. 'Buy now, pay later' credit schemes are increasingly being used to pay for everyday items like food, bus passes and school uniforms. Leading debt advisors have told the BBC that more women are juggling these debts as they struggle to cope with the cost of living. BBC Yorkshire investigations reporter, Stephanie Miskin, and Rebecca Routledge from debt advice organisation Money Wellness talk to Clare. Jackie Clune is an actor, writer and performer whose eclectic career has included a Karen Carpenter tribute act, Shakespeare, Mamma Mia! and most recently the narrator in a UK tour of The Rocky Horror Show. On screen, she's familiar to many as Motherland's school secretary Mrs Lamb, but she's also written novels and a memoir about unexpectedly becoming a mum to triplets at 39 and finding herself with four children under 19 months. She's now on stage in The Meat Kings! (Inc.) of Brooklyn Heights at London's Park Theatre, playing a tough, no-nonsense boss fighting to keep the family business afloat. She joins Clare to discuss the play, parenting and grief. A rare 500-year-old English parchment birth scroll is to be shown in the UK for the first time following recent pioneering analysis that confirmed its use during pregnancy and childbirth. The medieval scroll is central to Expecting: Birth, Belief and Protection at the Wellcome Collection exploring the protective practices and beliefs around pregnancy, childbirth and infertility that existed in medieval times. Dr Elma Brenner, Research Development Lead at Wellcome Collection and Professor Valerie Worth, Fellow of Trinity college oxford who holds a research grant from the Leverhulme Trust talk to Clare.Presented by: Clare McDonnell Produced by: Dianne McGregor

Three employees are gunned down at a northeast San Antonio landscaping business by a coworker who later took his own life. A Southern California woman leads police on a two-hour chase from Ventura County to the U.S.–Mexico border, crossing into Mexico before authorities could stop her. Drew Nelson reports.See omnystudio.com/listener for privacy information.

Originally developed as an anesthetic in the 1960s, ketamine has reemerged as one of modern psychiatry's most promising tools for treatment-resistant depression, anxiety, and post-traumatic stress disorder. Its superpower lies in working with your brain's glutamate receptors to create antidepressant effects. What does the future of psychedelic-assisted mental health care hold? Could this once-stigmatized molecule represent the future of mental health care and healing the mind from within?In this episode, we are joined by Dr. Mai Shimada, M.D., MBA, FAAEM. Dr. Shimada is a board-certified emergency medicine physician with over a decade of experience and is the founder and CEO of Isha Health, an online at-home ketamine clinic dedicated to providing safe and effective treatments for depression and anxiety.Dr. Shimada received her MD from the University of Tokyo, Emergency Medicine residency in the United States, and later on, completed the Psychedelic Facilitation Certification Program at the UC Berkeley Center for the Science of Psychedelics in two areas and the Ketamine-Assisted Psychotherapy Training Program at Polaris Insight Center. Currently, alongside Isha Health, Dr. Shimada is a study physician for psychedelic medicine clinical trials at Open Mind Collective, a Fellow of the American Academy of Emergency Medicine (FAAEM), a member of The American Board of Preventive Medicine (ABPM), and a visiting professor of Medicine at Tohoku University in Japan. Dr. Shimada has been featured on Forbes Japan.Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

Dr. Jonathan Payne is a Professor and Chair of Geological Sciences at Stanford University. He also holds a courtesy appointment in Biology, is a Member of Stanford's interdisciplinary biosciences institute Bio-X, and is an Affiliate of the Stanford Woods Institute for the Environment. Jonathan studies the history of life on Earth. He is interested in the interactions between the changes in earth's environments and the evolution of life on Earth. In particular, Jonathan focuses on large extinction events like asteroid impacts and volcanic eruptions, and how these impacted life in the oceans. When not working, Jonathan is often going to sporting events, traveling, and playing Nerf basketball in his house with his wife and two kids. He also enjoys hiking and working out at the gym. Jonathan received his B.A. in Geosciences from Williams College. Afterwards, he worked as a high school math and science teacher in Switzerland for two years before returning to graduate school. Jonathan was awarded his Ph.D. in Earth and Planetary Sciences from Harvard University, and he conducted postdoctoral research at Pennsylvania State University before joining the faculty at Stanford. Jonathan has received many awards and honors for his work, including the Stanford University Medal for excellence in advising undergraduate research, the Charles Schuchert Award from the Paleontological Society, and a CAREER Award from the National Science Foundation. He has also been named a Fellow of the Geological Society of America as well as a Fellow of the Paleontological Society. In this podcast interview, Jonathan spoke with us about his experiences in life and science.

This week host @Jackgreenstalk (aka @Jack_Greenstalk on X/instagram backup account) [or contact via email: JackGreenstalk47@gmail.com] is joined by panel with @spartangrown on instagram or X f.k.a. Twitter at https://x.com/grown43626 or email spartangrown@gmail.com for contacting spartan outside social media, any alternate profiles on other social medias using spartan's name, and photos are not actually spartan grown be aware, and @TheAmericanOne on youtube aka @theamericanone_with_achenes on instagram who's amy aces can be found at amyaces.com , and Rust Brandon of @fulcropsciences / fulcrop.ceo who's products can be found at bokashiearthworks.com and This week we missed @NoahtheeGrowa on instagram , Rust Brandon of @fulcrop.sciences / fulcrop.ceo who's products can be found at bokashiearthworks.com, Matthew Gates aka @SynchAngel on instagram and twitter @Zenthanol on youtube who offers IPM direct chat for $1 a month on patreon.com/zenthanol , @drmjcoco from cocoforcannabis.com as well as youtube where he tests and reviews grow lights and has grow tutorials and @drmjcoco on instagram, and and @ATG Acres Aaron The Grower aka @atgacres his products can be found at atgacres.com and now has product commercially available in select locations in OK, view his instagram to find out details about drops!

In this week's episode of the Infinite Potential of Being Human Podcast Nicky is joined by Fiona Arrigo, Founder of The Arrigo Programme, Biodynamic psychotherapist, Mentor and Healer. In this episode, explore the possibility of a New Earth, one built through coherence, remembrance, and the courage to live from truth rather than survival.Diving into how the breakdowns we're witnessing in the world, in our systems, our relationships, and our inner lives, aren't the end, but a threshold of something profoundly new.— You'll Learn: How to hold your centre when the world feels chaotic or fragmentedWhat coherence truly means within yourself, your relationships, and the collectiveWhy the collapse of old systems is not a failure, but a necessary initiationPractices to return to presence, prayer, and deep feminine wisdomAnd lots more!—Fiona ArrigoFiona Arrigo is a leading visionary in holistic health and founder of The Arrigo Programme, renowned for its deep therapeutic care and integrative approach to healing. Launching Britain's first alternative health retreat, Stop the World, in 1990, Fiona pioneered emotional detox retreats that remain profoundly relevant today.A Fellow of Biodynamic Medicine and senior Biodynamic Psychologist, Fiona draws on decades of study in ancient teachings, Eastern philosophy, and contemporary psychology. Her approach is deeply human, practical, and transformative. Her own healing journey began after surviving two near-fatal car accidents, which led her to remarkable teachers and a lifelong path of spiritual inquiry.Affectionately known as a “grandmother of many traditions,” Fiona has a natural gift for bringing people together, helping them reconnect with their essence, wisdom, and joy. Her guidance supports those seeking to reassess their life stories and find greater peace and purpose.Founded in 2001, The Arrigo Programme brings together gifted practitioners to create bespoke healing experiences focused on the mind, body, and emotions. Fiona also offers one-to-one consultations, individual and group retreats in Somerset, Spain, and India, alongside virtual programmes.A global thought leader dedicated to regeneration and “the Aquarian way,” Fiona continues to inspire new ways of being — healing ourselves, our communities, and the planet.For more information:Please visit her website: www.thearrigoprogramme.comAnd find her on Instagram: @thearrigoprogramme & @fiona_arrigo— Ready to Go Deeper? Access Nicky's FREE Discovering Freedom Masterclass: https://nickyclinch.lpages.co/the-discovering-freedom-masterclass/In this powerful masterclass, you'll:Identify the root of the repeating patterns that have been running your lifeDiscover who you truly are beyond the fears and stories that have kept you stuckLearn the foundations of the BodyMind Maturation Method™ and how to use it in your own lifeTake your first step toward creating lasting freedom in your relationships, work, and self-expressionThis is your invitation to go beyond surface-level change and start transforming at the root.— Connect with Nicky: Visit my website: https://nickyclinch.com/ Find me on Instagram: https://www.instagram.com/nicky_clinch/ Find me on Facebook: https://www.facebook.com/nickyclinchmaturation Let's connect on LinkedIn: https://uk.linkedin.com/company/nicky-clinch-surrender---This is just the beginning. And from this space, everything is possible.

On a returning HOW DO YOU DO, FELLOW KIDS? (the world's finest Steve Buscemi-themed podcast) we're heading back to the past with Bill Sherwood's gay romantic drama PARTING GLANCES from 1986, featuring Steve Buscemi's breakout performance as Nick, an HIV-positive rock musician. Two straight dudes talking about a pioneering queer work? It happened! Now you can hear it and all the latest Steve Buscemi news. Enjoy! The post Episode 289 – How Do You Do, Fellow Kids? – Parting Glances (1986) first appeared on Cinema Smorgasbord.

I. The fact that Paul prays to God for fellow believers, v16. II. The thanks he gives to God for fellow believers, vv15-16. III. The request he makes to God for fellow believers, v17

“We couldn't start inkjet again if we had it in our hands because we're not meeting the rules.” That stark admission from former HP Fellow Will Allen reveals why even the most innovative companies struggle to recreate their own breakthroughs—and what it takes to actually scale disruptive technology.In this episode, Will Allen, holder of 102 US patents and the first HP Fellow promoted within HP's Global Print Business, takes us inside three decades of Silicon Valley innovation from logic analyzers to consumer inkjet printing to his current role as CTO at Kaspix, where he's pioneering ultra-low-power AI inference using analog circuits. We explore why research should be treated as investment portfolio management (not an expense to cut), how “showing beats telling” when getting buy-in for radical ideas, and why getting AI to the “true edge” – directly at sensors and actuators – will fundamentally change computing economics.What You'll Discover:[00:00] Why Research and Development Are Two Different Things→ The fatal mistake of treating R&D as a single expense line when research is actually an investment with portfolio-level returns[06:03] Has Silicon Valley Run Out of Ideas?→ Why scaling success creates the very constraints that prevent future innovation, and whether we're less innovative than decades past[10:12] The Scaling Trap That Kills Success→ Real HP story: how field-fixing problems scaled so badly that engineers couldn't design problems out, and what this means for any growing business[16:23] Getting Past the “$100 Million Question”→ How to navigate corporate demand for predictable returns when developing something the market has never seen before[18:03] “A Functioning Proto Is Worth a Thousand Pictures”→ The clownfish story: how a weekend demo got low-drop-volume printing approved after months of rejection, and the art of communicating on stakeholders' terms[21:16] Signal Spotting and Fundamental vs Killer Apps→ Will's framework for distinguishing noise from transformational trends—and why asking “what's the killer app?” might be the wrong question[24:47] Kaspix and the True Edge→ Why analog circuits for AI inference could be as transformative as the mouse, enabling intelligence directly at transducers without memory-compute bottlenecks[29:56] Where AI Is Actually Heading→ Beyond the hype: specialized AIs, “AI middle management,” and why rapid societal change from deterministic technology creates uncomfortable transitions[36:04] The Advice Will Would Give His Younger Self→ Why leaders who invested years in education suddenly think quarterly, and how to reclaim the long-term thinking that got you thereAbout Will Allen:Will Allen is CTO at Kaspix, pioneering ultra-low-power AI inference through analog circuit design. Previously, he spent 30 years at HP, becoming the first HP Fellow promoted within HP's Global Print Business. He designed the color imaging pipeline used in HP's first 4 million color consumer inkjet printers, led IP production in HP Labs' AI and Emerging Compute Lab, and holds 102 issued US patents across printing, displays, robotics, and digital imaging.Related Links:Will's LinkedIn ProfileWill's Professional HomepageWill's YouTube ChannelKaspixKaspix Founder Pablo Zegers interviewed on The Innovators Podcast by John Biggs

Dr. Pedro Barata and Dr. Aditya Bagrodia discuss the evolving landscape of testicular cancer survivorship, the impact of treatment-related complications, and management strategies to optimize long-term outcomes and quality of life. TRANSCRIPT:  Dr. Pedro Barata: Hello and welcome to By the Book, a podcast series from ASCO that features engaging conversations between editors and authors of the ASCO Educational Book. I'm Dr. Pedro Barata. I'm a medical oncologist at University Hospitals Seidman Cancer Center and associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. We all know that testicular cancer is a rare but highly curable malignancy that mainly affects young men. Multimodal advances in therapy have resulted in excellent cancer specific survival, but testicular cancer survivors face significant long term treatment related toxicities which affect their quality of life and require surveillance and management. With that, I'm very happy today to be joined by Dr. Aditya Bagrodia, a urologic oncologist, professor, and the GU Disease Team lead at UC San Diego[KI1]  Health, and also the lead author of the recently published paper in the ASCO Educational Book titled, "Key Updates in Testicular Cancer: Optimizing Survivorship and Survival." And he's also the host of the world-renowned BackTable Urology Podcast. Dr. Bagrodia, I'm so happy that you're joining us today. Welcome. Dr. Aditya Bagrodia: Thanks, Pedro. Absolutely a pleasure to be here. Really appreciate the opportunity. Dr. Pedro Barata: Absolutely.  So, just to say that our full disclosures are available in the transcript of this episode.  Let's get things started. I'm really excited to talk about this. I'm biased, I do treat testicular cancer among other GU malignancies and so it's a really, really important topic that we face every day, right? Fortunately, for most of these patients, we're able to cure them. But it always comes up the question, "What now? You know, scans, management, cardio oncology, what survivorship programs we have in place? Are we addressing the different survivorship piece, psychology, fertility, et cetera?" So, we'll try to capture all of that today. Aditya, congrats again, you did a fantastic job putting together the insights and thoughts and what we know today about this important topic. And so, let's get focused specifically about what happens when patients get cured. So, many of us, in many centers, were fortunate enough to have these survivorship programs together, but I find that sometimes from talking to colleagues, they're not exactly the same thing and they don't mean the same thing to different people, to different institutions, right? So, first things first. What do you tell a patient perhaps when they ask you, "What can happen to me now that I'm done with treatment for testicular cancer?" Whether it's chemotherapy or just surgery or even radiation therapy? "So, what about the long term? What should I expect, Doctor, that might happen to me in the long run?" Dr. Aditya Bagrodia: Totally. I mean, I think that question's really front and center, Pedro, and really appreciate you all highlighting this topic. It was an absolute honor to work with true thought leaders and the survivorship bit of it is front and center, in my opinion. It's really the focus, you know, we, generally speaking should be able to cure these young men, but it's the 10, 15, 20 years down the way that they're going to largely contend with. The conversation really begins at diagnosis, pre-education. Fortunately, the bulk of patients that present are those with stage one disease, and even very basic things like before orchiectomy, talking about a prosthetic; we know that that can impact body image and self esteem, whether or not they decide to receive it or not. Actually, just being offered a prosthetic is important and this is something, you know, for any urologist, it's kind of critical. To discussing fertility elements to this, taking your time to examine the contralateral testicle, ask about fertility problems, issues, concerns, offer sperm banking, even in the context of a completely normal contralateral testicle, I think these things are quite important.  So if it's somebody with stage one disease, you know, without going too far down discussing adjuvant therapy and so forth, I will start the conversation with, "You know, the testes do largely two things. They make testosterone and they make sperm." By and large, patients are going to be able to have acceptable levels of testosterone, adequate sperm parameters to maintain kind of a normal gonadal state and to naturally conceive, should that be something they're interested in. However, there's still going to be, depending on what resource you look at, somewhere in the order of 10-30% that are going to have issues. Where I think for the stage one patients, it's really incumbent upon us is actually to not wait for them to discuss their concerns, particularly with testosterone, which many times can be a little bit vague, but to proactively ask about it every time. Libido, erectile quality, muscle mass maintenance, energy, fatigue. All of these are kind of associated symptoms of hypogonadism. But for a lot of kids 18-20 years old, it's going to be something insidious that they don't think about. So, for the stage one patients, it absolutely starts with gonadal function. If they are stage two getting surgery, I think the counseling really needs to center around a possibility for ejaculatory dysfunction. Now, for a chemotherapy-naive, nerve-sparing RPLND, generally these days we should be able to preserve ejaculatory function at high volume centers, but you still want to bring that up and again kind of touch base on thinking about sperm banking and so forth before the operation, scars, those are things I think worth talking about, small risk of ascites. Then, I think the intensity of potential long term adverse effects really ramps up when we're talking about systemic therapy, chemotherapy. And then there's of course some radiation therapy specific elements that come up. So, for the chemotherapy bits of it, I really think this is going to be something that can be a complete multi-system affected intervention. So, anxiety, depression, our group has actually shown using some population resources that even suicidality can be increased among patients that have been treated for germ cell tumor. You know, really from the top down, tinnitus, hearing changes, those are things that we need to ask about at every appointment. Neuropathy, sexual health, that we kind of talked about, including ED (erectile dysfunction), vertigo, dizziness, Raynaud's phenomenon, these are kind of more the symptoms that I think we need to inquire about every time. And what we do here and I think at a lot of survivorship programs is use kind of a battery of validated instruments, germ cell tumor specific, platinum treated patient specific. So we use a combination of EORTC questions and PROMIS questions, which actually serves as like a review of systems for the patient, also as a research element. We review that and then depending on what might be going on, we can dig into that further, get them over to colleagues in audiology or psychology, et cetera.  And then of course, screening for the hypertension, hyperlipidemia, metabolic syndrome with basically you or myself or somebody kind of like us serving, many times it's the role of the PCP, just making sure we're checking out, you know, CBC, CMP, et cetera, lipid parameters to screen for those kind of cardiac associated issues along with secondary malignancies. Dr. Pedro Barata: So that's super comprehensive and thorough. Thank you so much. Actually, I love how you break it down in a simple way. Two functions of the testes, produce testosterone and then, you know, the problem related to that is the hypogonadism, and then the second, as you mentioned, produce sperm and of course related to the fertility issues with that.  So, let's start with the first one that you mentioned. So, you do cite that in your paper, around 5-10% of men end up getting, developing hypogonadism, maybe clinical when they present with symptoms, maybe subclinical. So, I'm wondering, for our audience, what kind of recommendations we would give for addressing that or kind of thinking of that? How often are you ordering those tests? And then, when you're thinking about testosterone replacement therapy, is that something you do immediately or are there any guidelines into context that? How do you approach that? Dr. Aditya Bagrodia: So, just a bit more on digging into it even in terms of the questions to ask, you know, "Do you have any decrease in sexual drive? Any erectile dysfunction? Are your morning erections still taking place? Has the ejaculate volume changed? Physically, muscle mass, strength? Have you been putting on weight? Have you noticed increase in body fat?" And sometimes this is complicated because there's some anxiety that comes along with a cancer diagnosis when you're 20, 30 years old, multifactorial, hair loss, hot flashes, irritability. Sometimes they'll, you know, literally they'll say, "You know, my significant other or partners noticed that I'm really just a little bit labile." So I think, you know, there's the symptoms and then checking, usually kind of a gonadal panel, FSH, LH, free and total testosterone, sex hormone binding globulin, that's going to be typically pretty comprehensive. So if you've got symptoms plus some laboratory work, and ideally that pre-orchiectomy testosterone gives you some delta. If they started out at an 800, 900, now they're 400, that might be a big change for them. And then, when you talk about TRT (Testosterone Replacement Therapy) recommendations, you know, Pedro, yourself, myself, we're kind of lucky to be at academic centers and we've got men's health colleagues that are ultra experts, but at a high level, I would say that a lot of the TRT options center around fertility goals. Exogenous testosterone treats the low T, but it does suppress gonadal function, including spermatogenesis. So if that's not a priority, they can just get TRT. It should be done under the care of a urologist, a men's health, an endocrinologist, where we're checking liver chemistries and CBCs and a PSA and so forth. If they're interested in fertility preservation, then I would say engaging an endocrinologist, men's health expert is important. There's medications even like hCG, Clomid, which works centrally and stimulate the gonadal access. Niche scenarios where they might want standard TRT now, and then down the way, 5, 7 years, they're thinking about coming off of that for fertility purposes, I think that's really where you want to have an expert involved because there's quite a bit of nuance there in recovery of actual spermatogenesis and so forth.  To kind of summarize, you got to ask about it. Checking it is, is not overly complicated. We do a baseline pre-orchiectomy and at least once annually, you can tag it in with the tumor markers, so it's not an extra blood draw. And if they have symptoms of course, kind of developed, then we'll move that up in the evaluation. Dr. Pedro Barata: Got it. And you also touch base on the fertility angle, which is truly important. And I'm just curious, you know, a lot of times many of us might see one, two patients a year, right, and we forget these protocols and what we've got to do about that.  And so I'm interested to hear your thoughts about when you think about fertility, and how proactive you get. In other words, who do you refer for the fertility clinic, for a fertility preservation program? You know, do all cases despite getting through orchiectomy or just the cases that you're going to, you know you're going to seek chemotherapy at some point? What kind of selection or it depends on the chemo, like how do you do that assessment about the referral for preservation program that you might have available at UCSD? Dr. Aditya Bagrodia: Yeah, I mean I feel really fortunate to sit on the NCCN Testis Cancer Guidelines. It's in there that fertility counseling should be discussed prior to orchiectomy. So 100% bring it up. If there are risk factors, undescended testicles, previous history of fertility concerns, atrophic contralateral testicle, anything on the ultrasound like microlithiasis in the contralateral testicle, you kind of wanna get it there. And then again, there's kind of niche scenarios where you're really worried, maybe get a semen analysis and it doesn't look that good, arrange for the time of orchiectomy to have onco-testicular sperm extraction from the, quote unquote, "normal" testis parenchyma. You know, I think you have to be kind of prepared to go that route and really make sure you're doing this completely comprehensively.  So pre-orchiectomy all patients. Don't really push for it too hard if they've got a contralateral testicle, if they've had no issues having children. There's some cost associated with this, sperm banking still isn't kind of covered even in the context of men with cancer. If they've got risk factors, absolutely pre-orchiectomy. Pre-RPLND, even though the rates of ejaculatory dysfunction at a high-volume center should be low single digits, I'll still offer it. That'd be a real catastrophe if they were in that small proportion of patients and now they're going to be reliant on things like intrauterine insemination, where it becomes quite expensive.  Pre-chemo, everybody. That's basically a standard these days where it should be discussed and it's kind of amazing currently, even if you don't have an accessible men's health fertility clinic, there are actually companies, I have no vested interest, Fellow is one such company where you can actually create an account, receive a FedEx semen analysis and cryopreservation kit, send it back in, and all CLIA certified, it's based out of California. The gentleman that runs it, is a urologist and very, very bright guy who's done a lot of great stuff for testis cancer. So, even for patients that are kind of in extremis at the hospital that kind of need to get going like yesterday, we still discuss it. We've got some mechanisms in place to either have them take a semen analysis over to our Men's Health clinic or send it off to Fellow, which I think is pretty cool and that even extends to some of our younger adolescent patients where going to a clinic and providing a sample might be tricky.  So, I think bringing it up every stage, anytime there's an intervention that might be offered, orchiectomy, chemo, surgery, radiation, it's kind of incumbent on us to discuss it. Dr. Pedro Barata: Gotcha. That's super helpful. And you also touch base on another angle, which is the psychosocial angle around this. You mentioned suicidal rates, you mentioned anxiety, perhaps depression in some cases as well as chronic fatigue, not necessarily just because of the low testosterone that you can get, but also from a psychological perspective. I'm curious, what do the recommendations look like for that? Do these patients need to see a social worker or a psychologist, or do they need to answer a screening test every time they come to see us and then based on that, we kind of escalate, take the next steps according to that? Do they see a psychologist perhaps every so often? How should that be managed and addressed? Dr. Aditya Bagrodia: It's an excellent question and again, these can be rather insidious symptoms where if you don't really dig in and inquire, they can be glossed over. I mean, how easy to say, "Your markers look okay, your scans look okay. See you in six months," and keep it kind of brief. First off, I think bringing it up proactively and normalizing it, that, "This may be something that you experience. Many people do, you're not alone, there's nothing kind of wrong with you." I also think that this is an area where support groups can be incredibly useful. We host the Testicular Cancer Awareness Foundation support group here. They'll talk about chemo brain or just like a little bit of an adjustment disorder after their diagnosis. Support groups, I think are critical. As I mentioned, we have a survivorship program that's led by a combination of our med oncs, myself on the uro-onc side, as well as APPs, where we are systematically asking about essentially the whole litany of issues that may arise, including psychosocial, anxiety, depression, suicidality. And we've got a nice kind of fast path into our cancer center support services for these young men to meet with a psychologist. If that isn't going to be sufficient, they can actually see a psychiatrist to discuss medications and so forth. I do think that we've got to screen for these because, as anticipated from diagnosis, those first 2 years, we see a rise. But even 10, 15 years out, we note, compared to controls, that there is an increased level of anxiety, depression, suicidality that might not just take place at that initial acute period of diagnosis and treatment. Dr. Pedro Barata: Really well said. Super important.  So I guess if I were to put all these together, with these really amazing advances in technology, we all know AI, some of us might be more or less aware of biomarkers coming up, including microRNA for example, and others, like as I think of all these potential long term complications for these patients, look at the future, I guess, can we use this as a way to deescalate treatment where it's not really necessary, as a way to actually prevent some of these complications? Like, how do we see where we're heading? As we manage testicular cancer, let's say, within the next 5 or 10 years, do you think there's something coming up that's going to be different from what we're doing things today? Dr. Aditya Bagrodia: Totally. I mean, I think it's as exciting as a time as there's ever been, you know, maybe notwithstanding circa 1970s when platinum was discovered. So microRNAs, which you mentioned, you know, there's a new candidate biomarker, microRNA-371. We are super excited here at UCSD. We actually have it CLIA-certified available in our lab and are ordering these tests for patients kind of in their acute stage, you know, stage one and surveillance, stage two, post-RPLND, receiving chemotherapy. And essentially this is a universal germ cell tumor specific biomarker, except for teratoma, suffice it to say 90% sensitive and specific. And I think it's going to change the way that we diagnose and manage patients. You know, pre-orchiectomy, that's pretty straightforward. Post-orchiectomy, maybe we can really decrease the number of CT scans that are done. Maybe we can identify those patients that basically have occult disease where we can intervene early, either with RPLND or single cycle chemo. Post-RPLND, identify the patients who are at higher risk of relapse that may benefit from some adjuvant therapy. In the advanced setting, look at marker decline for patients in addition to standard tumor markers. Can we modulate their systemic therapy?  So, the international interest is largely on modifying things. There's really cool clinical trials that we have for stage one patients, that treatment would be prescribed based on a post-orchiectomy microRNA. I think the microRNAs are really exciting. Teratoma remains an outstanding question. I think this is where maybe ctDNA, perhaps some radiomics and advanced imaging processing and incorporating AI may allow us to safely avoid a lot of these post-chemo RPLNDs. And then identification using SNPs and so forth of who might be most susceptible to some of the cardiac toxicity, autotoxicity and personalizing things in that way as well. Dr. Pedro Barata: Super exciting, right, what's about to come? And I agree with you, I think it's going to change dramatically how we manage this disease.  This has been a pleasure sitting down with you. I guess before letting you go, anything else you'd like to add before we wrap it up? Dr. Aditya Bagrodia: Yeah, first off, again, just want to thank you and ASCO for the opportunity. And it's easy enough to, I think, approach a patient with the testicular germ cell tumor as, "This is an easy case. We're just going to do whatever we've done. Go to the guidelines that says do X, Y, or Z." But there's so much more nuance to it than that. Getting it done perfectly, I think, is mandatory. Whatever we do is an impact on them for the next 50, 60, 70 years of their life. And I found the germ cell tumor community, people are really passionate about it. If you're ever uncertain, there's experts throughout the country and internationally. Ask somebody before you do something that you can't undo. I think we owe it to them to get it perfect so that we can really maximize the survivorship and the survival like we've been talking about. Dr. Pedro Barata: Aditya, thanks for sharing your fantastic insights with us on this podcast. Dr. Aditya Bagrodia: All right, Pedro. Fantastic. Appreciate the opportunity. Dr. Pedro Barata: And also, thank you to our listeners for your time today. I actually encourage you to check out Dr. Bagrodia's article in the 2025 ASCO Educational Book. We'll post a link to the paper in the show notes. Remember, it's free access online, and you can actually download it as well as a PDF. You can also find on the website a wealth of other great papers from the ASCO Educational Book on key advances and novel approaches that are shaping modern oncology.  So with that, thank you everyone. Thank you, Aditya, one more time, for joining us. Thank you, have a good day. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:         Dr. Pedro Barata  @PBarataMD   Dr. Aditya Bagrodia @AdityaBagrodia Follow ASCO on social media:         @ASCO on X (formerly Twitter)         ASCO on Bluesky        ASCO on Facebook         ASCO on LinkedIn         Disclosures:      Dr. Pedro Barata:  Stock and Other Ownership Interests: Luminate Medical  Honoraria: UroToday  Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon  Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas  Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck   Dr. Aditya Bagrodia: Consulting or Advisory Role: Veracyte, Ferring  

Professor Ian Walmsley is Provost of Imperial College London and Chair in Experimental Physics. He has a distinguished career as a researcher, both in the UK and overseas. He is a Fellow of the Royal Society and has many awards and honours, including a CBE.  Ian has a specialist interest in quantum information processing and leads a research group in this field. He is about to step down from his role at Imperial and take on the leadership of the Oxford Quantum Institute. In this podcast we explore what quantum computing is and how non-specialists like me might think of it. 

The Game Changers podcast celebrates true pioneers who inspire us to take the big step forward and up in education and beyond. In episode 204 (Part 3) of Game Changers, Phil Cummins joins in conversation with Dr Ellen Heyting! Ellen is a passionate and experienced educator, researcher, and facilitator who works at Melbourne Metrics within the Faculty of Education at The University of Melbourne. She has over a decade of teaching and leadership experience in K-12 IB World Schools in Melbourne, Beijing, Singapore and Helsinki. She holds a PhD in Education from Monash University, a Master's degree in Education and a Bachelor of Arts (Hons) in Psychology and Media & Communication from the University of Melbourne, and a Graduate Certificate of Higher Education from Deakin University. She is also a Fellow of the Australian Council of Educational Leaders and the Higher Education Academy (HEA), both credentials that recognises her commitment to excellence in teaching and learning. Ellen's research interests include international school teacher identity, the assessment of complex competencies, the International Baccalaureate, and the power of agency in learning. She has led various projects, including the New Metrics International Schools Program, run in partnership between Melbourne Metrics and CIS as well as projects that support agency in learning, rethinking assessment and professional learning communities. Ellen believes that education can be a force to unite people for peace, justice, and a sustainable future, and strives to empower teachers, leaders and learners to develop the competencies they need to thrive at school and beyond. The Game Changers podcast is produced by Evan Phillips supported by a School for tomorrow (aschoolfortomorrow.com), and powered by CIRCLE Education. The podcast is hosted on SoundCloud and distributed through Spotify, Google Podcasts, and Apple Podcasts. Please subscribe and tell your friends you like what you are hearing. You can contact us at gamechangers@circle.education, on Twitter and Instagram via @GameChangersPC, and you can also connect with Phil via LinkedIn, Twitter and Instagram. Let's go!

Listen to this powerful interview with Dr. David Fajgenbaum who has an incredible new memoir, "Chasing My Cure: A Doctor's Race to Turn Hope into Action". David's story is truly unique; it's a tale of learning to live, while dying: a universally relatable story about getting up and fighting back after life knocks you down.A former Georgetown quarterback nicknamed "The Beast," David Fajgenbaum was also a force in medical school, where he was known for his unmatched mental stamina. But things changed dramatically when he began suffering from inexplicable fatigue. In a matter of weeks, his organs were failing and he was read his last rites. Doctors were baffled over a condition they had yet to even diagnose; floating in and out of consciousness, Fajgenbaum prayed for the equivalent of a game day overtime: a second chance.Miraculously, Fajgenbaum survived, but only to endure repeated near-death relapses from what would eventually be identified as a form of Castleman disease—an extremely deadly and rare condition that acts like a cross between cancer and an autoimmune disorder. When he relapsed on the only drug in development and realized that the medical community was unlikely to make progress in time to save his life, Fajgenbaum turned his desperate hope for a cure into concrete action: between hospitalizations he studied his own charts and tested his own blood samples, looking for clues that could unlock a new treatment. With the help of family, friends and mentors, he also reached out to other Castleman disease patients and physicians, and eventually came up with an ambitious plan to crowdsource the most promising research questions and recruit world- class researchers to tackle them; instead of waiting for the scientific stars to align, he proposed to align them himself.More than five years later and now married to his college sweetheart, his hard work has paid off: a treatment that he identified has induced a tentative remission and his novel approach to collaborative scientific inquiry has become a blueprint for advancing rare disease research. His incredible story demonstrates the potency of hope, and what can happen when forces of determination, love, family, faith and serendipity collide.David Fajgenbaum, MD, MBA, MSc is one of the youngest individuals to be appointed to the faculty at Penn Medicine. Co- founder and executive director of the Castleman Disease Collaborative Network (CDCN) and an NIH-funded physician- scientist, he has dedicated his life to discovering new treatments and cures for deadly disorders like Castleman disease, which he was diagnosed with during medical school. He is in the top 1 percent youngest grant awardees of an R01, one of the most competitive and sought-after grants in all of biomedical research. Dr. Fajgenbaum has been recognized on the Forbes 30 Under 30 healthcare list, as a top healthcare leader by Becker's Hospital Review, and one of the youngest people ever elected as a Fellow of the College of Physicians of Philadelphia, the nation's oldest medical society. He was one of three recipients – including Vice President Joe Biden – of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Order "Chasing My Cure" at bookstores nationwide or at http://www.chasingmycure.com/Business Leadership Series Intro and Outro music provided by Just Off Turner: https://music.apple.com/za/album/the-long-walk-back/268386576

As much of daily life migrates online, broadband—high-speed internet connectivity—has become a necessity. The widespread lack of broadband in rural America has created a stark urban–rural digital divide. In Farm Fresh Broadband: The Politics of Rural Connectivity (MIT Press, 2021), Dr. Christopher Ali analyzes the promise and the failure of national rural broadband policy in the United States and proposes a new national broadband plan. He examines how broadband policies are enacted and implemented, explores business models for broadband providers, surveys the technologies of rural broadband, and offers case studies of broadband use in the rural Midwest. Ali argues that rural broadband policy is both broken and incomplete: broken because it lacks coordinated federal leadership and incomplete because it fails to recognize the important roles of communities, cooperatives, and local providers in broadband access. For example, existing policies favor large telecommunication companies, crowding out smaller, nimbler providers. Lack of competition drives prices up—rural broadband can cost 37 percent more than urban broadband. The federal government subsidizes rural broadband by approximately $6 billion. Where does the money go? Ali proposes democratizing policy architecture for rural broadband, modeling it after the wiring of rural America for electricity and telephony. Subsidies should be equalized, not just going to big companies. The result would be a multi-stakeholder system, guided by thoughtful public policy and funded by public and private support. Dr. Christopher Ali is Associate Professor in the Department of Media Studies at the University of Virginia and is also the author of Media Localism: The Policies of Place. He is a Knight News Innovation Fellow with the Tow Center for Digital Journalism at Columbia University and former Fellow with the Benton Institute for Broadband & Society. Michael O. Johnston, Ph.D. is Assistant Professor of Sociology at William Penn University. His most recent research, “The Queen and Her Royal Court: A Content Analysis of Doing Gender at a Tulip Queen Pageant,” was published in Gender Issues Journal. He researches culture, social identity, placemaking, and media representations of social life at festivals and celebrations. He is currently working on a book titled Community Media Representations of Place and Identity at Tug Fest: Reconstructing the Mississippi River. You can learn more about Dr. Johnston on his website, Google Scholar, on Twitter @ProfessorJohnst, or by email at johnstonmo@wmpenn.edu. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

As much of daily life migrates online, broadband—high-speed internet connectivity—has become a necessity. The widespread lack of broadband in rural America has created a stark urban–rural digital divide. In Farm Fresh Broadband: The Politics of Rural Connectivity (MIT Press, 2021), Dr. Christopher Ali analyzes the promise and the failure of national rural broadband policy in the United States and proposes a new national broadband plan. He examines how broadband policies are enacted and implemented, explores business models for broadband providers, surveys the technologies of rural broadband, and offers case studies of broadband use in the rural Midwest. Ali argues that rural broadband policy is both broken and incomplete: broken because it lacks coordinated federal leadership and incomplete because it fails to recognize the important roles of communities, cooperatives, and local providers in broadband access. For example, existing policies favor large telecommunication companies, crowding out smaller, nimbler providers. Lack of competition drives prices up—rural broadband can cost 37 percent more than urban broadband. The federal government subsidizes rural broadband by approximately $6 billion. Where does the money go? Ali proposes democratizing policy architecture for rural broadband, modeling it after the wiring of rural America for electricity and telephony. Subsidies should be equalized, not just going to big companies. The result would be a multi-stakeholder system, guided by thoughtful public policy and funded by public and private support. Dr. Christopher Ali is Associate Professor in the Department of Media Studies at the University of Virginia and is also the author of Media Localism: The Policies of Place. He is a Knight News Innovation Fellow with the Tow Center for Digital Journalism at Columbia University and former Fellow with the Benton Institute for Broadband & Society. Michael O. Johnston, Ph.D. is Assistant Professor of Sociology at William Penn University. His most recent research, “The Queen and Her Royal Court: A Content Analysis of Doing Gender at a Tulip Queen Pageant,” was published in Gender Issues Journal. He researches culture, social identity, placemaking, and media representations of social life at festivals and celebrations. He is currently working on a book titled Community Media Representations of Place and Identity at Tug Fest: Reconstructing the Mississippi River. You can learn more about Dr. Johnston on his website, Google Scholar, on Twitter @ProfessorJohnst, or by email at johnstonmo@wmpenn.edu. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/environmental-studies

Fellow support group member Derek shares about growing up in extreme poverty and isolation. Recently he has been learning how to connect and practice boundaries but is still struggling with being attracted to women who treat him badly.This episode is sponsored Quince. Go to www.Quince.com/mental for free shipping on your order and 365-day returns. Now available in Canada, too.This episode is sponsored by NOCD. If you're struggling with OCD or unrelenting intrusive thoughts, NOCD can help. Book a free 15 minute call to get started: https://learn.nocd.com/mentalpodIf you're interested in seeing or buying the furniture that Paul designs and makes follow his IG @ShapedFurniture or visit the website www.shapedfurniture.com WAYS TO HELP THE MIHH PODCASTSubscribe via Apple Podcasts (or whatever player you use). It costs nothing. It's extremely helpful to have your subscription set to download all episodes automatically. https://itunes.apple.com/us/podcast/mental-illness-happy-hour/id427377900?mt=2Spread the word via social media. It costs nothing.Our website is www.mentalpod.com our FB is www.Facebook.com/mentalpod and our Twitter and Instagram are both @Mentalpod Become a much-needed Patreon monthly-donor (with occasional rewards) for as little as $1/month at www.Patreon.com/mentalpod Become a one-time or monthly donor via PayPal at https://mentalpod.com/donateYou can also donate via Zelle (make payment to mentalpod@gmail.com) To donate via Venmo make payment to @Mentalpod See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In the field of Eating Disorders, we are seeing an increasing occurrence of Mast Cell Activation Syndrome (MCAS) in our clients. In this episode, we talk to Dr. Jennifer Gaudiani to learn more about this overlap, signs and symptoms of MCAS , how it impacts healing from an eating disorder and treatment. Resources mentioned in the show:Four part blog series on MCAS and EDs by Dr. GGaudiani Clinic MCAS Questionnaires (RASH-PF and Q)About Dr. Jennifer GaudianiJennifer L. Gaudiani, MD, CEDS-S, FAED, is the Founder and Medical Director of  the Gaudiani Clinic. Board Certified in Internal Medicine, she completed her  undergraduate degree at Harvard, medical school at Boston University School of  Medicine, and her internal medicine residency and chief residency at Yale. Dr.  Gaudiani served as the Medical Director at the ACUTE Center for Eating Disorders  prior to founding the Gaudiani Clinic, which is a Denver-based outpatient medical  clinic dedicated to people with eating disorders and disordered eating. The Gaudiani  Clinic is a HAES (Health At Every Size)®-informed provider and embraces treating  people of all shapes, sizes, ages, and genders. The Gaudiani Clinic is licensed to  practice in over 35 US states via telemedicine and offers international professional  consultation and education.Dr. Gaudiani has lectured nationally and internationally, is widely published in the  scientific literature as well as on blogs, is a Fellow of the Academy for Eating  Disorders, and is a recent former member of the editorial board of the International  Journal of Eating Disorders and the Academy for Eating Disorders Medical Care  Standards Committee. Dr. Gaudiani's first book, Sick Enough: A Guide to the Medical Complications of Eating Disorders (Routledge, 2018) is available on  Amazon._______________________________________________________________This podcast is intended for informational and educational purposes only and does not constitute a provider-patient relationship. Please seek the support of a local therapist if you are currently struggling and in need of treatment. To find out more about what therapeutic services I offer visit my website at: www.eatingdisorderocdtherapy.comAs always, you can find me on IG @bodyjustice.therapist

The Compact for Academic Excellence in Higher Education. Peter Berkowitz (Hoover Institution Fellow and educator) discusses the Trump administration's "Compact for Academic Excellence in Higher Education," which requires universities to meet ten priorities to qualify for federal benefits like student loans and research grants. While many goals are proper or already legally required (like protecting free speech and obeying civil rights laws), several are highly controversial. These controversial points include demanding that hiring decisions be made solely on individual "merit," which critics redefine to include group diversity, and requiring universities to maintain institutional neutrality on political issues. Most universities rejected the compact, asserting it would impair academic freedom. Berkowitz suggests the administration should use direct financial incentives to reward universities that actively teach free speech, rather than relying on mandates. 1913 Princeton

Regulating AI and Protecting Children. Kevin Frazier (Law School Fellow at the University of Texas at Austin) addresses the growing concern over AI chatbots following tragedies, noting that while only 1.9% of ChatGPT conversations relate to "relationships," this fraction still warrants significant attention. He criticizes early state legislative responses, such as Illinois banning AI therapy tools, arguing that such actions risk denying mental health support to children who cannot access human therapists. Frazier advocates against imposing restrictive statutory law on the rapidly evolving technology. Instead, he recommends implementing a voluntary, standardized rating system, similar to the MPA film rating system. This framework would provide consumers with digestible information via labels—like "child safe" or "mental health appropriate"—to make informed decisions and incentivize industry stakeholders to develop safer applications. 1941

The Compact for Academic Excellence in Higher Education. Peter Berkowitz (Hoover Institution Fellow and educator) discusses the Trump administration's "Compact for Academic Excellence in Higher Education," which requires universities to meet ten priorities to qualify for federal benefits like student loans and research grants. While many goals are proper or already legally required (like protecting free speech and obeying civil rights laws), several are highly controversial. These controversial points include demanding that hiring decisions be made solely on individual "merit," which critics redefine to include group diversity, and requiring universities to maintain institutional neutrality on political issues. Most universities rejected the compact, asserting it would impair academic freedom. Berkowitz suggests the administration should use direct financial incentives to reward universities that actively teach free speech, rather than relying on mandates. 1901 Stanford

Regulating AI and Protecting Children. Kevin Frazier (Law School Fellow at the University of Texas at Austin) addresses the growing concern over AI chatbots following tragedies, noting that while only 1.9% of ChatGPT conversations relate to "relationships," this fraction still warrants significant attention. He criticizes early state legislative responses, such as Illinois banning AI therapy tools, arguing that such actions risk denying mental health support to children who cannot access human therapists. Frazier advocates against imposing restrictive statutory law on the rapidly evolving technology. Instead, he recommends implementing a voluntary, standardized rating system, similar to the MPA film rating system. This framework would provide consumers with digestible information via labels—like "child safe" or "mental health appropriate"—to make informed decisions and incentivize industry stakeholders to develop safer applications. 1919

The universe as revealed by physics is objective: it's out there, existing and behaving in ways that are completely independent of human thought. But the process by which we learn about the universe, and the language with which we talk about it, is extremely human-dependent. Does that mean that aliens would do science differently, and even think differently about physics, even if we all live in the same universe? Physicist Daniel Whiteson has teamed with cartoonist Andy Warner to investigate these questions in their new book Do Aliens Speak Physics?Blog post with transcript: https://www.preposterousuniverse.com/podcast/2025/11/03/334-daniel-whiteson-on-the-physics-of-and-by-aliens/Support Mindscape on Patreon.Daniel Whiteson received his Ph.D. in physics from the University of California at Berkeley. He is currently a professor of physics at the University of California, Irvine. He is a Fellow of the American Physical Society and recipient of an Emmy nomination. He is the author of several books, often with co-author Jorge Cham. He is the co-host (with Kelly Weinersmith) of the podcast Daniel and Kelly's Extraordinary Universe.UCI web pageGoogle Scholar publicationsAmazon author pageWikipediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.